| 2025-11-14 |
详情>>
内部人交易：
Xue Bing股份减少1845.00股
|
| 2025-11-06 |
详情>>
股本变动：
变动后总股本3006.15万股
|
| 2025-11-06 |
详情>>
业绩披露：
2026年一季报每股收益-0.07美元,归母净利润-212.2万美元,同比去年增长14.98%
|
| 2025-11-05 |
财报披露：
美东时间 2025-11-05 盘后发布财报
|
| 2025-09-18 |
股东大会：
将于2025-11-12召开股东大会
会议内容 ▼▲
- 1.To elect nine nominees to serve as directors on the Board of Directors of the Company (the “Board”) until the next annual general meeting of shareholders or until their successors are duly elected and qualified;
2.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as described in this Proxy Statement;
3.To approve an amendment and restatement of the Company’s 2018 Omnibus Incentive Plan to, among other things, increase the number of common shares authorized for issuance under such plan from 4,609,000 shares to 5,202,000 shares;
4.To approve and ratify the appointment of Deloitte & Touche, LLP as the Company’s independent registered public accounting firm, and to authorize the Board, acting through our Audit Committee, to determine the remuneration of such accounting firm, for the fiscal year ending June 30, 2026;
5.To approve the adjournment of the Annual Meeting to a later date, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for the approval of the other proposals contained herein.
|
| 2025-08-28 |
详情>>
业绩披露：
2025年年报每股收益-3.3美元,归母净利润-9697.6万美元,同比去年增长-775.16%
|
| 2025-08-28 |
详情>>
业绩披露：
2023年年报每股收益0.45美元,归母净利润1236.40万美元,同比去年增长-97.27%
|
| 2025-05-08 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.68美元,归母净利润-1991.7万美元,同比去年增长-138.56%
|
| 2025-02-06 |
详情>>
业绩披露：
2025年中报每股收益-0.31美元,归母净利润-911万美元,同比去年增长-418.2%
|
| 2024-11-05 |
详情>>
业绩披露：
2025年一季报每股收益-0.09美元,归母净利润-249.6万美元,同比去年增长-143.14%
|
| 2024-09-25 |
股东大会：
将于2024-11-08召开股东大会
会议内容 ▼▲
- 1.To elect nine nominees to serve as directors on the Board of Directors of the Company (the “Board”) until the next annual general meeting of shareholders or until their successors are duly elected and qualified;
2.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as described in this Proxy Statement;
3.To approve an amendment and restatement of the Company’s 2018 Omnibus Incentive Plan to, among other things, increase number of common shares authorized for issuance under such plan from 4,232,000 shares to 4,609,000 shares;
4.To approve and ratify the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm, and to authorize the Board, acting through our Audit Committee, to determine the remuneration of such accounting firm, for the fiscal year ending June 30, 2025.
|
| 2024-08-23 |
详情>>
业绩披露：
2024年年报每股收益-0.39美元,归母净利润-1108.1万美元,同比去年增长-189.62%
|
| 2024-08-23 |
详情>>
业绩披露：
2022年年报每股收益16.93美元,归母净利润4.53亿美元,同比去年增长679.76%
|
| 2024-05-08 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.3美元,归母净利润-834.9万美元,同比去年增长-161.99%
|
| 2024-02-07 |
详情>>
业绩披露：
2024年中报每股收益0.10美元,归母净利润286.30万美元,同比去年增长-91.16%
|
| 2023-11-07 |
详情>>
业绩披露：
2024年一季报每股收益0.21美元,归母净利润578.60万美元,同比去年增长-77.78%
|
| 2023-09-25 |
股东大会：
将于2023-11-10召开股东大会
会议内容 ▼▲
- 1.To elect nine (9) nominees to serve as directors on the Board of Directors of the Company (the "Board") until the next annual general meeting of shareholders or until their successors are duly elected and qualified;
2.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as described in this Proxy Statement;
3.To approve, on an advisory basis, whether the advisory shareholder vote to approve the compensation of the Company’s named executive officers should occur every year, once every two years or once every three years;
4.To approve an amendment and restatement of the Company’s 2018 Omnibus Incentive Plan;
5.To approve an amendment and restatement of the Company’s 2018 Employee Share Purchase Plan;
6.To approve and ratify the appointment of Baker Tilly US, LLP as the Company's independent registered public accounting firm, and to authorize the Board, acting through our Audit Committee, to determine the remuneration of such accounting firm, for the fiscal year ending June 30, 2024.
|
| 2022-10-13 |
股东大会：
将于2022-11-29召开股东大会
会议内容 ▼▲
- 1.The election of nine (9) nominees to serve as directors on our Board until the next annual general meeting of shareholders or until their successors are duly elected and qualified. The affirmative vote of a plurality of the votes cast at the Annual Meeting is required for the election of directors. “Plurality” means that the individuals who receive the highest number of votes are elected as directors, up to the number of directors to be chosen at the meeting. A properly executed proxy marked “withhold authority” with respect to the election of one or more directors will not be voted with respect to the director or directors indicated, although it will be counted for purposes of determining whether there is a quorum. Broker non-votes will have no effect on the outcome of the election of directors.
2.The approval, on an advisory basis, the compensation of our named executive officers as described in the Proxy Statement, commonly known as the “say-on-pay” vote. This proposal is deemed to be approved by shareholders if it receives the affirmative vote of holders of a majority of the votes cast in person or represented by proxy and entitled to vote at the Annual Meeting. However, Proposal 2 represents only an advisory vote of shareholders and is not binding on the Company, although our Board will consider results of the vote in setting the compensation of our named executive officers. Abstentions and broker non-votes will have no effect on the outcome of this proposal.
3.The approval of the amendment and restatement of the Company’s 2018 Omnibus Incentive Plan to increase the number of common shares authorized to be issued under such plan. The affirmative vote of holders of a majority of the votes cast in person or represented by proxy and entitled to vote at the Annual Meeting will be required to approve this proposal. Abstentions and broker non-votes will have no effect on the outcome of this proposal.
4.The approval and ratification of the appointment of Baker Tilly US, LLP (“Baker Tilly”) as our independent registered public accounting firm, and the authorization for our Board, acting through our Audit Committee to determine the remuneration of the accounting firm, for the fiscal year ending June 30, 2023. The affirmative vote of holders of a majority of the votes cast in person or represented by proxy and entitled to vote at the Annual Meeting will be required to approve this proposal. Abstention will have no effect on the outcome of this proposal.
|
| 2021-10-01 |
股东大会：
将于2021-11-11召开股东大会
会议内容 ▼▲
- 1.To elect nine (9) nominees to serve as directors on the Board of Directors of the Company (the "Board") until the next annual general meeting of shareholders or until their successors are duly elected and qualified;
2.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as described in this Proxy Statement;
3.To approve an amendment to the Company’s 2018 Omnibus Incentive Plan to increase number of common shares authorized for issuance under such plan from 2,065,000 shares to 3,065,000 shares.
4.To approve an amendment to the Company’s 2018 Employee Share Purchase Plan to increase the number of common shares authorized for issuance under such plan from 1,430,000 shares to 2,500,000 shares.
5.To approve and ratify the appointment of BDO USA, LLP as the Company's independent registered public accounting firm, and to authorize the Board, acting through our Audit Committee, to determine the remuneration of such accounting firm, for the fiscal year ending June 30, 2022.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-09-28 |
股东大会：
将于2020-11-12召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) nominees to serve as directors on the Board of Directors of the Company (the "Board") until the next annual general meeting of shareholders or until their successors are duly elected and qualified;
2.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as described in this Proxy Statement;
3.To approve a resolution to permit the Board to determine the maximum number of directors on the Board and to fill casual vacancies and appoint additional directors from time to time.
4.To approve and ratify the appointment of BDO USA, LLP as the Company's independent registered public accounting firm, and to authorize the Board, acting through our Audit Committee, to determine the remuneration of such accounting firm, for the fiscal year ending June 30, 2021.
|
| 2019-10-07 |
股东大会：
将于2019-11-08召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) nominees to serve as directors on our Board of Directors until the next annual general meeting of shareholders or until their successors are duly elected and qualified;
2.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as described in this Proxy Statement;
3.To approve an amendment to the Company’s 2018 Omnibus Incentive Plan (the “2018 Plan”) to increase the number of common shares authorized for issuance under the 2018 Plan;
4.To approve and ratify the appointment of BDO USA, LLP as our independent registered public accounting firm, and to authorize our Board of Directors, acting through our Audit Committee, to determine the remuneration of such accounting firm, for the fiscal year ending June 30, 2020.
|
| 2018-10-09 |
股东大会：
将于2018-11-09召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) nominees to serve as directors on our Board of Directors until the next annual general meeting of shareholders or until their successors are duly elected and qualified;
2.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as described in this Proxy Statement;
3.To approve the adoption of the Company’s 2018 Omnibus Incentive Plan;
4.To approve the adoption of the Company’s 2018 Employee Share Purchase Plan;
5.To approve and ratify the appointment of BDO USA, LLP as our independent registered public accounting firm, and to authorize our Board of Directors, acting through our Audit Committee, to determine the remuneration of such accounting firm, for the fiscal year ending June 30, 2019.
|
| 2017-10-03 |
股东大会：
将于2017-11-09召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) nominees to serve as directors on our Board of Directors until the next annual general meeting of shareholders or until their successors are duly elected and qualified;
2.To approve an amendment to our Amended and Restated Bye-laws (“Bye-laws”) to increase the authorized number of common shares from 50,000,000 shares to 100,000,000 shares;
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as described in this Proxy Statement;
4.To approve, on an advisory basis, whether the advisory shareholder vote to approve the compensation of the Company’s named executive officers should occur every year, once every two years or once every three years;
5.To approve and ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm, and to authorize our Board of Directors, acting through our Audit Committee, to determine the remuneration of such accounting firm, for the fiscal year ending June 30, 2018.
|
| 2016-10-03 |
股东大会：
将于2016-11-10召开股东大会
会议内容 ▼▲
- 1. To elect seven (7) nominees to serve as directors on our Board of Directors until the next annual general meeting of shareholders or until their successors are duly elected and qualified;
2. To approve and ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm, and to authorize our Board of Directors, acting through our Audit Committee, to determine the remuneration of such accounting firm, for the fiscal year ending June 30, 2017;
3. To consider and act upon such other business as may properly come before the Annual Meeting or any adjournment thereof.
|
| 2015-09-24 |
股东大会：
将于2015-11-10召开股东大会
会议内容 ▼▲
- 1.To elect six (6) nominees to serve as directors on our Board of Directors until the next annual general meeting of shareholders or until their successors are duly elected and qualified;
2.To approve an amendment of our Bye-laws to, among other things, update and clarify the advance notice requirements for general meetings of shareholders;
3.To approve and ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm, and to authorize our Board of Directors, acting through our Audit Committee, to determine the remuneration of such accounting firm, for the fiscal year ending June 30, 2016;
4.To consider and act upon such other business as may properly come before the Annual Meeting or any adjournment thereof.
|